Weighted Average Number of Shares Outstanding, Basic of NGM BIOPHARMACEUTICALS INC from 2019 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NGM BIOPHARMACEUTICALS INC quarterly and annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2019 to Q4 2023.
  • NGM BIOPHARMACEUTICALS INC Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2023 was 82,496,000, a 3.2% increase year-over-year.
  • NGM BIOPHARMACEUTICALS INC annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 82,496,000, a 3.2% increase from 2022.
  • NGM BIOPHARMACEUTICALS INC annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 79,950,000, a 3.7% increase from 2021.
  • NGM BIOPHARMACEUTICALS INC annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 77,085,000, a 13% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

NGM BIOPHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2023 82,496,000 +2,546,000 +3.2% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2024 2023 Q4
Q3 2023 82,707,000 +2,084,000 +2.6% 01 Jul 2023 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 82,456,000 +3,186,000 +4% 01 Apr 2023 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 82,008,000 +3,985,000 +5.1% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 79,950,000 +2,865,000 +3.7% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2024 2023 Q4
Q3 2022 80,623,000 +3,214,000 +4.2% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 79,270,000 +2,174,000 +2.8% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 78,023,000 +1,989,000 +2.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 77,085,000 01 Oct 2021 31 Dec 2021 10-K 11 Mar 2024 2023 Q4
Q3 2021 77,409,000 +8,593,304 +12% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 77,096,000 +8,790,944 +13% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 76,034,000 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q3 2020 68,815,696 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 68,305,056 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2

NGM BIOPHARMACEUTICALS INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 82,496,000 +2,546,000 +3.2% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2024 2023 FY
2022 79,950,000 +2,865,000 +3.7% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
2021 77,085,000 +8,610,000 +13% 01 Jan 2021 31 Dec 2021 10-K 11 Mar 2024 2023 FY
2020 68,475,000 +18,177,476 +36% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 50,297,524 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.